Literature DB >> 10899450

Mitochondrial impairment of human muscle in Friedreich ataxia in vivo.

M Vorgerd1, L Schöls, C Hardt, M Ristow, J T Epplen, J Zange.   

Abstract

Friedreich ataxia occurs due to mutations in the gene encoding the mitochondrial protein frataxin. This (31)P magnetic resonance spectroscopy study on the calf muscle of Friedreich ataxia patients provides in vivo evidence of a severe impairment of mitochondrial function. Mitochondrial adenosine triphosphate resynthesis was studied by means of the post-exercise recovery of phosphocreatine. After ischemic exercise in calf muscles of all patients, phosphocreatine recovery was dramatically delayed. Time constants of recovery correlated with mutations of the frataxin gene, the age of the patients, and disease duration. (31)P magnetic resonance spectroscopy represents the first expedient tool for monitoring therapeutic trials in Friedreich ataxia non-invasively.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10899450     DOI: 10.1016/s0960-8966(00)00108-5

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  25 in total

Review 1.  Treatment of glycogenosys type V (McArdle disease) with creatine and ketogenic diet with clinical scores and with 31P-MRS on working leg muscle.

Authors:  M Vorgerd; J Zange
Journal:  Acta Myol       Date:  2007-07

2.  A cross-validation of near-infrared spectroscopy measurements of skeletal muscle oxidative capacity with phosphorus magnetic resonance spectroscopy.

Authors:  Terence E Ryan; W Michael Southern; Mary Ann Reynolds; Kevin K McCully
Journal:  J Appl Physiol (1985)       Date:  2013-10-17

Review 3.  Mitochondrial fitness and insulin sensitivity in humans.

Authors:  J Szendroedi; M Roden
Journal:  Diabetologia       Date:  2008-09-19       Impact factor: 10.122

4.  Exercise capacity and idebenone intervention in children and adolescents with Friedreich ataxia.

Authors:  Bart E Drinkard; Randall E Keyser; Scott M Paul; Ross Arena; Jonathan F Plehn; Jack A Yanovski; Nicholas A Di Prospero
Journal:  Arch Phys Med Rehabil       Date:  2010-07       Impact factor: 3.966

5.  Assessment of in vivo skeletal muscle mitochondrial respiratory capacity in humans by near-infrared spectroscopy: a comparison with in situ measurements.

Authors:  Terence E Ryan; Patricia Brophy; Chien-Te Lin; Robert C Hickner; P Darrell Neufer
Journal:  J Physiol       Date:  2014-06-20       Impact factor: 5.182

Review 6.  The role of mitochondria in insulin resistance and type 2 diabetes mellitus.

Authors:  Julia Szendroedi; Esther Phielix; Michael Roden
Journal:  Nat Rev Endocrinol       Date:  2011-09-13       Impact factor: 43.330

7.  Nanopore Fabrication and Application as Biosensors in Neurodegenerative Diseases.

Authors:  Brian Lenhart; Xiaojun Wei; Zehui Zhang; Xiaoqin Wang; Qian Wang; Chang Liu
Journal:  Crit Rev Biomed Eng       Date:  2020

8.  Central role and mechanisms of β-cell dysfunction and death in friedreich ataxia-associated diabetes.

Authors:  Miriam Cnop; Mariana Igoillo-Esteve; Myriam Rai; Audrey Begu; Yasmina Serroukh; Chantal Depondt; Anyishai E Musuaya; Ihsane Marhfour; Laurence Ladrière; Xavier Moles Lopez; Dionysios Lefkaditis; Fabrice Moore; Jean-Pierre Brion; J Mark Cooper; Anthony H V Schapira; Anne Clark; Arnulf H Koeppen; Piero Marchetti; Massimo Pandolfo; Décio L Eizirik; Françoise Féry
Journal:  Ann Neurol       Date:  2012-12       Impact factor: 10.422

9.  Phosphorus-31 two-dimensional chemical shift imaging in the myocardium of patients with late onset of Friedreich ataxia.

Authors:  Christian Wolf; Sylvia Boesch; Bernhard Metzler; Helga Weirich-Schwaiger; Thomas Trieb; Michael F H Schocke
Journal:  Mol Imaging Biol       Date:  2007-11-14       Impact factor: 3.488

10.  Altered gene expression and DNA damage in peripheral blood cells from Friedreich's ataxia patients: cellular model of pathology.

Authors:  Astrid C Haugen; Nicholas A Di Prospero; Joel S Parker; Rick D Fannin; Jeff Chou; Joel N Meyer; Christopher Halweg; Jennifer B Collins; Alexandra Durr; Kenneth Fischbeck; Bennett Van Houten
Journal:  PLoS Genet       Date:  2010-01-15       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.